New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
Heartflow launched Heartflow Plaque Staging, a new risk-stratification tool based on total plaque volume, integrated into every Heartflow Plaque Analysis case. The launch is supported by eight new datasets from clinical studies spanning over 36,000 patients, presented at the SCCT 2026 Annual Scientific Meeting. Key data shows that over 50% of symptomatic patients with zero coronary artery calcium harbor significant non-calcified plaque, which traditional scoring misses but Heartflow detects.
Key figures
- Annotated cta images
- 200000000
- Institutions adopted
- 1800
- Reproducibility kappa
- 95%
- Total patients managed
- 650000
- Decide registry patients
- 11792
- Total patients in studies
- 36000
- Scanner transition patients
- 12269
- Tpv coefficient of variation
- 3%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.